Algert Global’s Kailera Therapeutics KLRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.01M Buy
+88,260
New +$1.49M 0.01% 1017

Other funds holding KLRA

Algert Global's KLRA Position: Q3 2026 in Review

Algert Global opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 88,260 shares worth $1.01M. The stake represents 0.01% of the portfolio and ranks #1017 among its holdings.

132 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

  • Algert Global held 88,260 shares of Kailera Therapeutics worth $1.01M as of Q3 2026.
  • Kailera Therapeutics was a new Algert Global position in Q3 2026.
  • Kailera Therapeutics made up 0.01% of Algert Global's portfolio in Q3 2026, its #1017 holding.
  • 132 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Algert Global's 13F filing for Q3 2026, filed 17 Nov 2026.